Ans J. Remmink
About
In The Last Decade
Ans J. Remmink
6 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Epidemiology 989
- Surgery 400
- Immunology 243
- Oncology 193
- Microbiology 177
Countries citing papers authored by Ans J. Remmink
This map shows the geographic impact of Ans J. Remmink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans J. Remmink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans J. Remmink more than expected).
Fields of papers citing papers by Ans J. Remmink
This network shows the impact of papers produced by Ans J. Remmink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans J. Remmink. The network helps show where Ans J. Remmink may publish in the future.
Co-authorship network of co-authors of Ans J. Remmink
This figure shows the co-authorship network connecting the top 25 collaborators of Ans J. Remmink. A scholar is included among the top collaborators of Ans J. Remmink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ans J. Remmink. Ans J. Remmink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study breakdown → | The Lancet | Marielle Nobbenhuis, Jan M.M. Walboomers et al. | 537 |
| 2 | Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. | PubMed | Tanja D. de Gruijl, Hetty J. Bontkes et al. | 95 |
| 3 | Immunoglobulin G Responses Against Human Papillomavirus Type 16 Virus-Like Particles in a Prospective Nonintervention Cohort Study of Women With Cervical Intraepithelial Neoplasia | JNCI Journal of the National Cancer Institute | Tanja D. de Gruijl, Hetty J. Bontkes et al. | 80 |
| 4 | T Cell Proliferative Responses Against Human Papillomavirus Type 16 E7 Oncoprotein are Most Prominent in Cervical Intraepithelial Neoplasia Patients with a Persistent Viral Infection | Journal of General Virology | Tanja D. de Gruijl, Hetty J. Bontkes et al. | 50 |
| 5 | Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasm indicates an association with clearance of viral infection: results of a prospective study | International Journal of Cancer | Tanja D. de Gruijl, Hetty J. Bontkes et al. | 22 |
| 6 | The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months | International Journal of Cancer | Ans J. Remmink, Jan M.M. Walboomers et al. | 300 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.